Delivery Order SPE2DB24D1104-SPE2DB24FXVY5
- Not listed
- This federal contract award, valued at $2,127.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of DEXAMETHASONE 10 MG/ML VIALML, a medical product, with a completion date of February 21, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,095.97 firm fixed-price delivery order has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. government, holding several Indefinite Delivery Contracts (IDCs) with...
- This federal contract award, valued at $1,943.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564572082 - DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2024 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the award information provided....
- This is a $4,128.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of 4568619457 ! DEXAMETHASONE 20 MG/5 ML VIAL 5ML. The contract has an ultimate completion date of June 24, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,524.24, is a Firm Fixed Price Delivery Order for the supply of Dexamethasone 10 mg/ml vials. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXAMETHASONE 4 MG TABLET 100S. The contract has a ceiling value of $1,011.00 and is a firm fixed price award from the Defense Logistics Agency, a defense agency. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the for-profit parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract, which has a potential value of $3,072.36, is for the delivery of Dexamethasone 20 mg/5 ml vials. This order does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,059.75, is for the delivery of 4,565,815,786 units of Dexamethasone 20 mg/5 ml vials. This is a firm-fixed price delivery order contract with a completion date of September 17, 2024. The contract is not set-aside. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of dexamethasone 20 mg/5 ml vial, a critical pharmaceutical product. The $2,376.00 firm-fixed-price contract has a performance period through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,280.12 firm fixed-price delivery order is for the supply of 10 mg/mL vials of the medication dexamethasone. The contract has an ultimate completion date of May 19, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FXVY5Delivery Order
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the provision of DEXAMETHASONE 20 MG/5 ML VIAL 5ML to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,332.11 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/25/24 |